Christoph Frohn

β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio (2006)

Luhm, Juergen, Langenkamp, Ulrich, Hensel, Jenny, Frohn, Christoph, Brand, Joerg M, Hennig, Holger, ...

Abstract Background β-1→3-D-glucans represent a pathogen-associated molecular pattern and are able to modify biological responses. Employing a comprehensive methodological approach, the aim of our...

NK-Lymphozyten für die Krebstherapie : von der Biologie zur klinischen Anwendung / (2003)

Frohn, Christoph.

Enth. ausserdem 7 Sonderabdr. aus verschiedenen Zeitschr. - Beitr. teilw. dt., teilw. engl.

Biochemische Analyse von Kallusgewebe bei einem Patienten mit Osteogenesis imperfecta Typ IV. (1990)

Frohn, Christoph.

Lübeck, Med. Univ., Diss., 1992.

β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio

Luhm, Juergen, Langenkamp, Ulrich, Hensel, Jenny, Frohn, Christoph, Brand, Joerg M, Hennig, Holger, ...

β-(1→3)-D-glucan modulates DNA binding of nuclear factors κB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1β/IL-1 receptor antagonist ratio

Luhm, Juergen, Langenkamp, Ulrich, Hensel, Jenny, Frohn, Christoph, Brand, Joerg M, Hennig, Holger, ...